These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7722177)

  • 1. Sublingual immunotherapy for cat allergy.
    Bousquet J; Michel FB; Creticos PS
    J Allergy Clin Immunol; 1995 Apr; 95(4):920-1. PubMed ID: 7722177
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract.
    Nelson HS; Oppenheimer J; Vatsia GA; Buchmeier A
    J Allergy Clin Immunol; 1993 Aug; 92(2):229-36. PubMed ID: 8349933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy with a standardized cat dander extract: evaluation of efficacy in a double blind placebo controlled study.
    Alvarez-Cuesta E; Berges-Gimeno P; González-Mancebo E; Fernández-Caldas E; Cuesta-Herranz J; Casanovas M
    Allergy; 2007 Jul; 62(7):810-7. PubMed ID: 17573730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of oral immunotherapy with standardized cat extract.
    Oppenheimer J; Areson JG; Nelson HS
    J Allergy Clin Immunol; 1994 Jan; 93(1 Pt 1):61-7. PubMed ID: 8308183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of allergoid immunotherapy: is cat allergy a suitable target?
    Nguyen NT; Raskopf E; Shah-Hosseini K; Zadoyan G; Mösges R
    Immunotherapy; 2016; 8(3):331-49. PubMed ID: 26860435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody-standardized cat extract immunotherapy: risk-benefit effects from a double-blind placebo study.
    Alvarez-Cuesta E; Cuesta-Herranz J; Puyana-Ruiz J; Cuesta-Herranz C; Blanco-Quirós A
    J Allergy Clin Immunol; 1994 Mar; 93(3):556-66. PubMed ID: 8151058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of ALLERVAX CAT in cat allergic patients.
    Maguire P; Nicodemus C; Robinson D; Aaronson D; Umetsu DT
    Clin Immunol; 1999 Dec; 93(3):222-31. PubMed ID: 10600332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy.
    Bauer CS; Rank MA
    J Allergy Clin Immunol; 2014 Sep; 134(3):765-765.e2. PubMed ID: 25171871
    [No Abstract]   [Full Text] [Related]  

  • 9. How does sublingual immunotherapy work?
    Frew AJ
    J Allergy Clin Immunol; 2007 Sep; 120(3):533-6. PubMed ID: 17765753
    [No Abstract]   [Full Text] [Related]  

  • 10. Sublingual immunotherapy: a comprehensive review.
    Cox LS; Larenas Linnemann D; Nolte H; Weldon D; Finegold I; Nelson HS
    J Allergy Clin Immunol; 2006 May; 117(5):1021-35. PubMed ID: 16675328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging concepts of sublingual immunotherapy for allergy.
    Theodoropoulos DS; Morris MS; Morris DL
    Drugs Today (Barc); 2009 Oct; 45(10):737-50. PubMed ID: 20069138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study.
    Bernardini R; Campodonico P; Burastero S; Azzari C; Novembre E; Pucci N; Massai C; De Martino M; Vierucci A
    Curr Med Res Opin; 2006 Aug; 22(8):1515-22. PubMed ID: 16870076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects associated with sublingual immunotherapy.
    Passalacqua G; Valovirta E
    Clin Allergy Immunol; 2008; 21():469-75. PubMed ID: 18828524
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy for house-dust mite allergy.
    Nelson HS
    Allergy Asthma Proc; 2018 Jul; 39(4):264-272. PubMed ID: 30095391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Well days' after sublingual immunotherapy with a high-dose 6-grass pollen preparation.
    Worm M
    Allergy; 2009 Jul; 64(7):1104-5. PubMed ID: 19385951
    [No Abstract]   [Full Text] [Related]  

  • 17. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract.
    Ewbank PA; Murray J; Sanders K; Curran-Everett D; Dreskin S; Nelson HS
    J Allergy Clin Immunol; 2003 Jan; 111(1):155-61. PubMed ID: 12532112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trials.
    Tao L; Shi B; Shi G; Wan H
    Clin Respir J; 2014 Apr; 8(2):192-205. PubMed ID: 24118881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of sublingual immunotherapy.
    Passalacqua G; Guerra L; Pasquali M; Lombardi C; Canonica GW
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):3-12; quiz 12-3, 103. PubMed ID: 15281466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract.
    Enrique E; Pineda F; Malek T; Bartra J; Basagaña M; Tella R; Castelló JV; Alonso R; de Mateo JA; Cerdá-Trias T; San Miguel-Moncín Mdel M; Monzón S; García M; Palacios R; Cisteró-Bahíma A
    J Allergy Clin Immunol; 2005 Nov; 116(5):1073-9. PubMed ID: 16275379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.